XBiotech names Shivaswamy and Simard co-CEOs effective October 23
The board elevated interim CEO Sushma Shivaswamy and longtime clinical staffer Jan-Paul Simard to share the chief executive role, per an 8-K filed October 26, 2026.
SEC filing
1 story
The board elevated interim CEO Sushma Shivaswamy and longtime clinical staffer Jan-Paul Simard to share the chief executive role, per an 8-K filed October 26, 2026.
SEC filing